A Brief Review on Anemia

Anemia is a common hematologic condition characterized by a deficiency in the number or quality of red blood cells (RBCs), leading to reduced oxygen-carrying capacity of the blood. It is a global health issue with various etiologies, including nutritional deficiencies (iron, vitamin B12, folic acid), chronic diseases, bone marrow disorders, and genetic conditions. The most prevalent form of anemia worldwide is iron-deficiency anemia, particularly in developing countries, often linked to poor dietary intake, malabsorption, or blood loss. Anemia can also result from chronic diseases such as kidney disease, inflammatory disorders, and cancer, where impaired RBC production or increased RBC destruction occurs. Hemoglobinopathies, including sickle cell disease and thalassemia, are inherited conditions that cause abnormal RBCs, contributing to anemia in specific populations. The clinical presentation of anemia varies depending on its severity and underlying cause. Common symptoms include fatigue, pallor, weakness, dizziness, and shortness of breath. In severe cases, heart palpitations, chest pain, and organ dysfunction may develop. Diagnosis is typically made through blood tests, including a complete blood count (CBC), reticulocyte count, and assessment of iron, vitamin B12, and folate levels. Bone marrow examination and genetic testing may be required for more complex cases. Treatment of anemia is tailored to the underlying cause. Iron supplementation is the mainstay for iron-deficiency anemia, while vitamin supplementation may be necessary for deficiencies in B12 or folate. In cases of anemia due to chronic disease or genetic disorders, managing the underlying condition is crucial. Blood transfusions, erythropoiesis-stimulating agents, or bone marrow stimulants may be required in more severe or refractory cases. Early diagnosis and intervention are vital for preventing complications and improving patient outcomes.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-10
DOI
https://doi.org/10.5281/zenodo.14364552
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Brief Review on Anemia

Zenodo (CERN European Organization for Nuclear Research)
Hemoglobinopathies and Related Disorders
article

A Brief Review on Anemia

article en

Abstract

Anemia is a common hematologic condition characterized by a deficiency in the number or quality of red blood cells (RBCs), leading to reduced oxygen-carrying capacity of the blood. It is a global health issue with various etiologies, including nutritional deficiencies (iron, vitamin B12, folic acid), chronic diseases, bone marrow disorders, and genetic conditions. The most prevalent form of anemia worldwide is iron-deficiency anemia, particularly in developing countries, often linked to poor dietary intake, malabsorption, or blood loss. Anemia can also result from chronic diseases such as kidney disease, inflammatory disorders, and cancer, where impaired RBC production or increased RBC destruction occurs. Hemoglobinopathies, including sickle cell disease and thalassemia, are inherited conditions that cause abnormal RBCs, contributing to anemia in specific populations. The clinical presentation of anemia varies depending on its severity and underlying cause. Common symptoms include fatigue, pallor, weakness, dizziness, and shortness of breath. In severe cases, heart palpitations, chest pain, and organ dysfunction may develop. Diagnosis is typically made through blood tests, including a complete blood count (CBC), reticulocyte count, and assessment of iron, vitamin B12, and folate levels. Bone marrow examination and genetic testing may be required for more complex cases. Treatment of anemia is tailored to the underlying cause. Iron supplementation is the mainstay for iron-deficiency anemia, while vitamin supplementation may be necessary for deficiencies in B12 or folate. In cases of anemia due to chronic disease or genetic disorders, managing the underlying condition is crucial. Blood transfusions, erythropoiesis-stimulating agents, or bone marrow stimulants may be required in more severe or refractory cases. Early diagnosis and intervention are vital for preventing complications and improving patient outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Partnerships for the goals
Openalex Percentile: Top 51%
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.